Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-Seq
Cardiology · 2023 · 148 (2) · 150-160
DOI: 10.1159/000529043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, online erschienen am 09.02.2023. Verfasst von Yun Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Putuo District People's Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, MicroRNAs, Ischemic Stroke, Exosomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the general population, and stroke is the most severe complication of AF. Exosomal miRNAs have been reported to be candidates as biomarkers for cardiovascular diseases, including AF and stroke. This study aimed to identify differentially expressed miRNAs (DEMs) in serum exosomes of AF and AF-associated ischemic stroke (AF-IS) patients and evaluate their potential in distinguishing AF and AF-IS patients.
Methods
Serum exosomes were isolated from 8 healthy individuals with sinus rhythm (SR controls), 8 AF patients, and 8 AF-IS patients. miRNA-seq was performed to identify DEMs, and qRT-PCR analysis was performed to confirm the sequencing results. A support vector machine (SVM) model was developed using Python to distinguish AF and AF-IS patients.
Results
68 and 86 DEMs were identified in serum exosomes of AF patients compared to AF-IS patients and SR controls, respectively. Levels of miR-641 and miR-30e-5p were found significantly higher in AF-IS patients. The SVM model achieved an accuracy of 100%, with an area under curve of 1.
Conclusions
The results indicated that miRNA expression profiles of serum exosomes in AF patients were distinct from those in AF-IS patients, and based on the distinction, AF and AF-IS patients can be distinguished.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Putuo District People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Department of Internal Neurology, Shanghai Putuo District People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Fun-med Pharmaceutical Technology (Shanghai) Co., Ltd., Shanghai, China.
Zitieren
APA
Xie, Y., Zhou, L., Yan, M., Zhao, W., & Hu, Z. (2023). Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-Seq. Cardiology, 148(2), 150-160. https://doi.org/10.1159/000529043
Vancouver
Xie Y, Zhou L, Yan M, Zhao W, Hu Z. Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-Seq. Cardiology. 2023;148(2):150-160. doi:10.1159/000529043
BibTeX
@article{Xie2023,
author = {Xie, Yun and Zhou, Lili and Yan, Meiyu and Zhao, Wei and Hu, Zhaoyang},
title = {Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-Seq},
journal = {Cardiology},
year = {2023},
volume = {148},
number = {2},
pages = {150--160},
doi = {10.1159/000529043}
}
EUVIMED